Anais Brasileiros de Dermatologia

Anais Brasileiros de Dermatologia

Volume 96, Issue 6, November–December 2021, Pages 787-790
Anais Brasileiros de Dermatologia

Research Letter
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain☆,☆☆

https://doi.org/10.1016/j.abd.2020.08.030Get rights and content
Under a Creative Commons license
open access

Cited by (0)

☆

How to cite this article: Pereyra-Rodriguez JJ, Dominguez-Cruz J, Armario-Hita JC, Villaverde RR. 104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain. An Bras Dermatol. 2021;96:787–90.

☆☆

Study conducted at the Hospital Universitario San Cecilio, Granada, Spain.

© 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.